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Abstract.
Background: Exploring the domains of cognitive function which are most strongly associated with future dementia may
help with understanding risk factors for, and the natural history of dementia.
Objective: To examine the association of performance on a range of cognitive tests (both global and domain specific) with
subsequent diagnosis of dementia through health services in a population of relatively healthy men and women and risk of
future dementia.
Methods: We examined the association between performance on different cognitive tests as well as a global score and
future dementia risk ascertained through health record linkage in a cohort of 8,581 individuals (aged 48–92 years) between
2004–2019 with almost 15 years follow-up (average of 10 years) before and after adjustment for socio-demographic, lifestyle,
and health characteristics.
Results: Those with poor performance for global cognition (bottom 10%) were almost four times as likely to receive a
dementia diagnosis from health services over the next 15 years than those who performed well HR = 3.51 (95%CI 2.61, 4.71
p < 0.001) after adjustment for socioeconomic, lifestyle, and biological factors and also prevalent disease. Poor cognition
performance in multiple tests was associated with 10-fold increased risk compared to those not performing poorly in any test
HR = 10.82 (95% CI 6.85, 17.10 p < 0.001).
Conclusion: Deficits across multiple cognitive domains substantially increase risk of future dementia over and above neu-
ropsychological test scores ten years prior to a clinical diagnosis. These findings may help further understanding of the natural
history of dementia and how such measures could contribute to strengthening future models of dementia.
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INTRODUCTION
There has been an increased interest in the pre-
vention or delay of the onset of dementia [1] and
of the early identification of individuals who are at
high risk [2]. For the purpose of primary preven-
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tion, we need a better understanding of the natural
progression of the disease to allow targeting of spe-
cific risk factors to potentially modify early biological
changes that may be an indication of future dementia
[3]. Although early diagnosis of dementia is recom-
mended in individuals displaying symptoms of the
condition [4], current policies do not support screen-
ing or risk prediction at an individual level among
apparently healthy individuals [3]. This is due to
uncertainty of clinical outcomes and effective inter-
ventions [5], with insufficient evidence of benefits
over the harms of screening for cognitive impairment
and dementia [4, 6]. Arguments against screening
highlight these uncertainties, including unnecessary
investigation and treatment with no evidence of any
benefit for the individual [7, 8].
Dementia for most has a long prodromal period,
whereby individuals who go onto develop demen-
tia, exhibit cognitive deficits many years before
any symptoms or receiving a clinical diagnosis [9].
Though difficult to discriminate dementia in its early
stages from normal cognitive ageing [10–12], there
is evidence from large cohort studies that, in gen-
eral, those who developed dementia after follow-up
exhibited poorer cognitive performance compared to
those who did not develop the disease [13], although
differences have been insufficient to translate into
accurate individual risk prediction [3]. The increased
risks have been observed for tests both at a global and
domain specific level [14, 15]. This includes episodic
memory, executive functioning, verbal ability, visu-
ospatial skill, attention, and processing speed [16,
17].
Dementia risk reduction has been identified one of
the top research priorities in reducing the global bur-
den of dementia [18]. Though not clinically applied,
numerous dementia risk models have been developed
and are widely used for research. These models have
a number of uses, such as to examine factors that are
associated with increased or reduce risk of dementia,
or to classify individuals into different risk categories
and in particular, identify those with high risk [19]
in order to and identify target populations for inter-
vention and prevention trials [3]. The accuracy of
dementia prediction models have been reported as
variable among different cohorts [19, 20].
Neuropsychological testing provides information
on the nature and extent of cognitive deficits, and
has been a core measure included in models of
dementia in addition to age [19, 21]. Many studies
have been limited either by small cognitive batteries
assessing few cognitive domains or using tools such
as the widely used Mini-Mental State Examination
[22] (MMSE) or the Montreal Cognitive Assessment
(MoCA), both known to be less sensitive to milder
levels of cognitive dysfunction [23–25]. It is neces-
sary to evaluate the utility of tests and to identify tests
that are sensitive to early changes [26].
Variability across tasks also indicates neurological
dysfunction [27]. Greater variability across different
cognitive domains has been associated with poorer
performance and dementia [28] and has been said
to be a good predictor of cognitive impairment over
and above the mean level of performance in individ-
ual cognitive tasks [29]. Furthermore, there is also
evidence of more pervasive cognitive deficits across
domains in earlier stages of decline, and not just mem-
ory alone [13, 30, 31]. Dementia is characterized by
severe deficits across a range of fluid cognitive abili-
ties, which worsens and affects more domains as the
disease progresses [32]. However, it is still unclear,
whether the cognitive performance is associated with
dementia across all cognitive functions or whether
it is specific to one or more key functions. Further
research with a wider range of neuropsychological
tests is needed [33, 34].
As well as the limitation of studies with cogni-
tive tests that are sensitive and broad-ranging [35],
there are fewer longitudinal studies [36] with suffi-
cient follow-up time [37]. Investigating the utility of
cognitive tests in individuals free of cognitive impair-
ment or dementia at the time of testing, across a wider
age range merits further investigation. Although large
prospective cohort studies have shown an associ-
ation between pre-clinical cognitive capability and
increased risk of dementia [21], there is little in the
current literature, on the level of impairment by cog-
nitive domain, and in studies with follow-ups of more
than 10 years [37]. The purpose of this study is to
provide additional insight, that is has not been clear
in previous studies, into the extent of impairment in
natural history of dementia to further inform potential
primary prevention strategies. A greater understand-
ing of the role of specific risk factors associated with
dementia is needed not only to understand the natural
history of dementia, but also to better inform future
risk prediction models when selecting components to
be included [20].
We examine the utility of a range of cognitive tests
(both global and domain specific), that are more sen-
sitive to earlier changes of decline as potential key
components, for risk of future dementia. We inves-
tigate whether early signs of impairment across a
number of cognitive tasks influences the associations
S.A. Hayat et al. / The Relationship Between Cognitive Performance Using Tests Assessing a Range of Cognitive Domains 125
with incident dementia over and above cognitive per-
formance on individual tasks, in a relatively healthy
ageing prospective cohort study of mid to later life.
METHODS
Study participants and data collection
The European Prospective Investigation of Can-
cer (EPIC) is a European wide study of diet and
health of which EPIC-Norfolk is one collaborating
center. At the inception of the study (1993–1997),
EPIC-Norfolk recruited 25,639 community-dwelling
men and women (40–79 years old) from GP registers
in and around the city of Norwich (Norfolk, United
Kingdom). This involved the completion of a health
and lifestyle questionnaire and a clinical examination
[38]. The data presented here are from the third health
examination (3HC) which was conducted between
2006 and 2011 with a preceding pilot phase between
2004 and 2006. Participants were aged 48–92 years,
with no report of overt cognitive problems at the
time of cognitive testing. The full assessment was a
comprehensive 3-h examination which included tests
assessing different domains of cognitive function. A
detailed description of the cohort both at inception
and at 3HC have been published [39, 40].
The study was approved by the Norfolk Local
Research Ethics Committee (05/Q0101/191) and
East Norfolk and Waveney NHS Research Gover-
nance Committee (2005EC07L). The study also has
approval for follow-up through record linkage (REC
Ref 98CN01). Informed consent was obtained from
all individual participants included in the study. This
study was conducted in compliance with the prin-
ciples expressed in the Declaration of Helsinki and
the Research Governance Framework for Health and
Social Care.
Assessment of cognition
The EPIC-Norfolk cognition battery at the 3HC
phase consisted of seven tests, assessing performance
across different cognitive domains. One of the tests,
Visual Sensitivity Test (VST) for processing speed,
had two outcome measures, thus giving a total of
eight separate cognitive measures. These test have
been described previously [40] and are summarized
in Table 1.
Covariates
Education and social class were ascertained
from health and lifestyle questionnaire adminis-
tered at baseline (1993–1997). Objective measures
of co-variates, such as cholesterol, systolic blood
pressure, body mass index (BMI), waist hip ratio
(WHR), forced expiratory volume in one second
(FEV1), blood pressure, and plasma vitamin C were
obtained from the clinical examination and physi-
cal activity, and prevalent disease were ascertained
from self-reported health and lifestyle questionnaire
administered at the time of the clinic appointment
Dementia ascertainment and diagnostic codes
Almost complete follow-up for disease outcomes
in EPIC-Norfolk has been established via linkage to
routinely collected National Health Service (NHS)
databases in England (Hospital Episode Statistics,
Table 1
List of the individual cognitive tests used in the EPIC-Norfolk
Name of test Predominant ability measured by test
(Description of score)
1 A shortened version of the Extended Mental State Exam
(SF-EMSE)
Global function (continuous score)
2 Hopkins Verbal Learning Test (HVLT) Verbal episodic memory (continuous score)
3 Cambridge Neuropsychological Test Automated Battery
Paired Associates Learning Test. First trial Memory
Score (CANTAB-PAL FTMS)
Non-verbal episodic memory (continuous score)
4 PW Letter Cancellation Task (PW-Accuracy Score) Attention (continuous score)
5 Event and Time Based Task (prospective memory) Prospective memory (dichotomous outcome, success or
fail)
6 Visual Sensitivity Test (VST)∗ (1)VST-Simple Simple and complex visual processing speed measured
in milliseconds (continuous score)
7 (2)VST-Complex
8 Shortened version of the National Adult Reading Test∗
(short-NART)
Reading ability and crystallised intelligence (continuous
score)
∗Higher score corresponds to poorer performance.
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HES) and mortality data for all participants using
their unique NHS number and date of birth. The
linked hospital records contain coded diagnostic
information for all inpatient and day-case admissions
[41]. To maximize dementia ascertainment, we also
obtained national mental healthcare data.
Incident dementias were defined as those people
free of dementia at the time of enrolment to the study,
and at the time of cognitive testing (at 3HC) but
identified with a dementia diagnosis through routine
records subsequently. Participants were followed up
from the date of consent at baseline until the first date
of a dementia diagnosis, date of death or censoring
with neither at 31 March 2019, allowing the timing of
dementia onset to be accurately ascertained. The hos-
pital and mortality and hospital data are coded using
the International Classification of Diseases version
10 (ICD-10) which are almost exclusively diagnostic
codes. Here, dementia from HES records, death cer-
tificate, or the mental health data was defined as any of
the ICD-10 codes as listed in Supplementary Table 1.
We used cases with a definite clinical diagnosis from
any cause dementia. The sub types of dementia were
not analyzed separately in this study.
Analyses
Associations were examined using approximate
percentile cut-offs rather than the continuous cogni-
tive score. Poor performance was defined as obtaining
a score less than a cut-off point corresponding to
approximately the 10th percentile of the population
distribution in each of the eight cognitive measures
individually. We have described previously, the ratio-
nale for using percentile cut-off’s in this population,
where the prevalence of cognitive impairment using
accepted standard diagnostic criteria is low and the
cognitive scores were not normally distributed [42,
43]. It was therefore necessary to establish opera-
tional criteria for cognitive dysfunction specific to
this population. Participants were classified into two
groups based on the cut-off scores for each of the
tests. For prospective memory, poor performance was
defined as those failing the task. A composite score
(EPIC-COGComp) was also created from the eight
individual cognitive measures. This composite rep-
resents general cognition underlying all the cognitive
functions assessed. Participants were classified in two
groups for the continuous composite score in the same
way as the scores were for the individual tests as
described above.
The risk of a ‘definite dementia’ diagnosis was esti-
mated as a hazard ratio with 95% confidence interval
(95%CI) for each of the cognitive tests in separate
Cox proportional hazard regression models. Age (at
time of cognitive testing), and multivariable-adjusted
models were additionally constructed to estimate
dementia risk. The models were as follows:
Model 1: Socio-demographic factors (age, per 5
years, sex, education, and social class).
Model 2: Socio-demographic and lifestyle (smok-
ing, physical activity, and alcohol).
Model 3: Socioeconomic, lifestyle, and biologi-
cal factors (cholesterol, systolic blood pressure, BMI,
WHR, FEV, and plasma vitamin C), and prevalent
disease.
The distribution of participants with poor cogni-
tive performance across the eight cognitive measures
were categorized based on the number of tests with a
poor performance score as follows: A, 4–8 tests; B,
2-3 tests; C, 1 test; D, 0 tests (Reference category).
Associations were examined with the number of tests
included as a categorical variable in in the multivari-
ate adjusted model (Model 3), and then additionally
adjusted for each cognitive test.
As a supplementary analysis, we used multivari-
able regression analysis to examine the potential
value of adding level of cognitive impairment to
improve the accuracy of predictive modelling for
dementia. We generated predicted probabilities from
multiple logistic regression, which were then used to
plot a receiver operating characteristic (ROC) curve
to derive the area under the curve (AUC). The pre-
dictor variables included models examined by ROC
were:
A: Age, sex and, education (basic model, as
reported in previously [21]).
B: Multi-variable adjusted model (socioeco-
nomic, lifestyle, biological factors, and prevalent
disease or Model 3).
C: Variables as in Model 3, also adjusted for com-
posite score (using the dichotomous variable of
the composite).
D: Variables as in Model 3, further adjusted
for ‘number of tests with poor performance’
(using the 4-level variable for number of tests,
as described above).
Missing data
Hazard ratios were examined by assigning par-
ticipants with missing data to either the poor
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performance or to the reference category. Hazard
ratios also examined for individuals with data on
all eight cognitive tests and the specified covariates
(N = 6,151) and compared to those with complete
missing data of any of the eight cognitive measures
as well as those not attending the health examination.
Sensitivity analyses
A number of sensitivity analyses were conducted.
Firstly, we grouped participants in approximate quar-
tiles of cognition scores to explore whether the
relationship of cognition and risk of dementia was
a continuum or threshold, using a different (less
stringent) grouping of the cognition scores. Sec-
ondly, we excluded participants who had died or were
diagnosed with dementia in the first five years of
follow-up to test for potential reverse causation bias.
RESULTS
Of the 8,623 individuals who took part in the 3HC,
8,585 had cognitive measures with a total of 537 with
a dementia diagnosis (based on the ICD codes in Sup-
plementary Table 1) after a maximum of 14.8 years
of follow up (mean of 9.6 and median of 9.8 years).
Four of these participants were excluded from the
analyses as they received their dementia diagnosis
prior to their cognitive assessment resulting in a total
of 533 dementia cases in the final analytical sample
of 8,581 men and women who were aged 48–92 at
the time of their cognitive assessment. Figure 1 sum-
marizes the participation level at each phase of the
study from baseline and the selection of the analyt-
ical sample. The total number of incident dementia
in EPIC-Norfolk participants from the 25,639 indi-
viduals who attended the baseline health check at the
censor date was 3,187.
Table 2 shows the means and proportions of the
variables included in this analysis by dementia status.
As expected, there were differences between the two
groups for almost all the variables examined. Those
with dementia were more likely to be older, have
no qualifications, be physically inactive and non-
drinkers, less likely to be current smokers, and have
higher blood pressure. They were also more likely
Fig. 1. Selection of study participants in the EPIC-Norfolk third health check (including pilot phase 2004–2006) for all-cause ‘definite’
dementia, followed until 31 March 2019.
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Table 2
Characteristics by dementia status of 8,581 participants with cognitive measures in the Third Health Check Phase of the European Prospective
Investigation of Cancer in Norfolk (EPIC-Norfolk) study, 2006–2011 (including pilot data, 2004–2006). Participants followed up until 31
March 2019
Definite dementia No dementia p
N = 537 N = 8,048
Socio-demographic
Mean (SD)
Age 76.3 (6.2) 68.2 (7.9) <0.001
Sex, % women (n) 50.3 (266) 55.6 (4476) 0.02
Marital status, % married (n) 69.8 (353) 78.8 (6204) <0.001
Education, % (n)
No qualifications 34.0 (180) 25.7 (2068) <0.001
O/A level standard 51.0 (270) 56.5 (4548)
Graduate level 14.9 (79) 17.8 (1434)
Social class, % (n)
Professional 7.8 (41) 8.9 (707) 0.5
Managerial 41.7 (220) 41.1 (3278)
Skilled non-manual 17.3 (91) 16.0 (1272)
Skilled manual 18.8 (99) 20.7 (1647)
Semi-skilled 12.7 (67) 11.1 (883)
∗Retired 76.3 (5904) 95.8 (483) <0.001
Non-skilled 1.7 (9) 2.3 (187)
Lifestyle
Physically inactive, % (n) 46.2 (237) 36.6 (2909) <0.001
Smoking status, % (n)
Current 3.3 (17) 4.4 (353) 0.01
Former 52.6 (270) 45.5 (3620)
Never 44.1 (226) 50.0 (3976)
Alcohol intake, % (n)
0 units 36.4 (180) 29.4 (2281) 0.004
1–14 units/week 54.1 (268) 59.1 (4586)
>14 units per week 9.5 (47) 11.5 (896)
Take part in regular social activities 66.7 (171) 64.4 (2830) 0.3
Biological/physiological
Body mass index (Kgs/M2) 26.7 (4.2) 26.8 (4.3) 0.4
Waist hip ratio 0.91 (0.08) 0.89 (’(0.08) 0.003
Total cholesterol in mmol/L 5.1 (1.17) 5.4 (1.1) <0.001
Systolic blood pressure, mmHg 138.5 (18.0) 136.0 (16.2) 0.001
Plasma vitamin C in umol/L 60.5 (22.4) 63.2 (22.3) 0.02
FEV (mL) 2.18 (0.7) 2.46 (0.7) <0.001
Prevalent disease
Co-morbidity, self-report Yes% (n)
Heart attack 4.0 (21) 3.4 (270) 0.5
Hypertension 37.8 (200) 24.8 (2000) <0.001
Stroke 4.5 (24) 2.0 (158) <0.001
Cancer 10.2 (54) 9.3 (750) 0.5
Diabetes 6.8 (36) 2.8 (224) <0.001
Depression 18.9 (100) 21.9 (1762) 0.1
COPD 9.3 (49) 8.1 (653) 0.4
Memory problems 7.4 (39) 1.9 (152) <0.001
Hearing problems 41.2 (218) 31.0 (2498) <0.001
Cognitive Test Score, Mean (SD)
SF-EMSE 29.8 (4.4) 32.8 (2.9) <0.001
HVLT 20.0 (6.4) 25.4 (5.5) <0.001
FTMS 12.7 (4.7) 15.8 (4.2) <0.001
PW-Accuracy 9.7 (6.6) 13.4 (5.9) <0.001
VST-Simple 722.0 (224.6) 660.2 (161.4) <0.001
VST-Complex 2378.0 (500.0) 2185.9 (421.7) <0.001
NART Error 17.4 (10.0) 17.2 (9.9) 0.7
Success frequency % (N)
Prospective memory 82.8 (6537) 57.5 (289) <0.001
∗From main occupation at time of cognitive testing P values by T test or Chi sq for proportion. HVLT, Hopkins Verbal Learning Test, ms,
milliseconds; N, number; PAL-FTMS, Paired Associated Learning, First Trial Memory Score; Pros. Mem, Prospective memory; PW-Acc,
PW-Accuracy, SD, standard deviation; SF-EMSE, Short Form Extended Mental State Exam; Sh-NART, Short National Adult Reading Test;
VST, Visual Sensitivity Test.
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Fig. 2. Distribution of poor performance across the eight measures in the EPIC-Norfolk cohort.
to have reported suffering from stroke, hypertension,
diabetes, and memory and hearing problems. Those
with subsequent dementia scored lower on all the cog-
nition tests at the 3HC, except the short-NART, which
is a test of reading ability and crystallized knowledge.
Of the 8,581 participants with cognitive data, 6,152
participants had data for all the cognitive tests with
2,391 having some of the test measures and 38 partic-
ipants having none. In the healthier cohort, over half
the participants did not exhibit poor performance in
any of the eight cognitive measures, 26.1% exhibited
poor performance in one test, 17.1% in 2-3 tests, and
4.8% in 4–8 tests (Fig. 2).
Hazard ratios for dementia, adjusted for age (at the
time of the invitation to the 3HC) per 5 years, sex,
education, and social class for those who attended
the health check and those who were invited but
did not attend (N = 9,605 – as shown in Fig. 2)
were examined. Using the group who had attended
3HC and had data on all 8 tests as reference, the
dementia risk (adjusted for age, sex, education, and
social class) were as follows: with data on 5–7
tests, HR = 1.12 (95%CI 0.93, 1.35 p = 0.2); 1–4 tests
HR = 1.38 (95%CI 0.95, 2.00 p = 0.1); attended 3HC,
but with no cognition data HR = 2.35 (95%CI 1.21,
4.57 p = 0.01), and for those who were invited for the
3HC but did not attend HR = 1.83 (95%CI 1.61, 2.08
p≤0.001). Data shown in Supplementary Table 2.
Table 3 shows the results of the Cox proportional
hazards analysis for all the tests separately and for
the composite score. For the age and sex adjusted
models, there was an increased risk of dementia in
those obtaining a poor performance score as com-
pared to those who did not for all the cognitive tests
other than the short-NART. Further adjustments for
education and social class (Model 2) and then for co-
variates, smoking, body mass index, physical activity,
and comorbidities (Model 3) made little difference
to the hazard ratios. The magnitude of the associa-
tion varied slightly across tests, with the association
with the composite as the strongest. Of the individual
tests, the HVLT, a test for verbal episodic memory
was comparable to the association observed for the
composite.
In the sensitivity analysis, imputing missing into
the poor performance or reference group, other than
some slight attenuation made little difference to the
hazard ratios (Supplementary Table 3). The anal-
yses based on quartiles on cognitive performance
showed no dose association in the quartile analy-
ses, particularly at the top end of performance scores.
(Supplementary Table 4). Therefore, using the more
stringent cut-off in this cohort of healthier and higher
functioning individuals is appropriate as presented
in the main analysis. Repeating the multivariable
analysis after excluding individuals who died or
received a dementia diagnosis within five years of
follow-up after cognitive testing (Number of demen-
tia cases = 426), resulted in slight attenuation of the
hazard ratios (Supplementary Table 5).
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Table 3
Association of cognitive performance (using the bottom 10th percentile as cut-off for poor performance) and dementia across the eight cognitive measures separately and a combined composite
score as measured in the EPIC-Norfolk Cohort (2006–2010), including pilot data (2004–2006)
Model 1 Model 2 Model 3
Test, freq (N) Frequency Dementia (N) HR 95% CI p Dementia (N) HR 95% CI p Dementia (N) HR 95% CI p
dementia % (N)*
SF-EMSE (8479) 521 519 351
Poor 18.4 (201) 3.09 (2.58, 3.70) <0.001 3.20 (2.67, 3.87) <0.001 3.16 (2.51, 3.98) <0.001
Good 4.3 (320) 1.00 1.00 1.00
p<0.001
HVLT (8135) 485 484 333
Poor 21.2 (175) 3.45 (2.84, 4.18) <0.001 3.56 (2.93, 4.34) <0.001 3.12 (2.44, 4.00) <0.001
Good 4.2 (310) 1.00 1.00 1.00
p<0.001
FTMS (7459) 437 436 289
Poor 15.4 (126) 2.06 (1.66, 2.55) <0.001 2.05 (1.66, 2.55) <0.001 2.11 (1.61, 2.78) <0.001
Good 4.7 (311) 1.00 1.00 1.00
p<0.001
PW-Acc (8406) 510 508 343
Poor 13.7 (133) 1.79 (1.47,2.19) <0.001 1.82 (1.49, 2.23) <0.001 1.78 (1.39, 2.28) <0.001
Good 5.1 (377) 1.00 1.00 1.00
p<0.001
VST-Simple (7169) 413 412 289
Poor 11.9 (85) 1.77 (1.39, 2.25) <0.001 1.80 (1.41, 2.29) <0.001 1.78 (1.33, 2.38) <0.001
Good 5.1 (328) 1.00 1.00 1.00
p<0.001
VST-Complex (7169) 413 412 289
Poor 14.8 (106) 2.15 (1.72, 2.69) <0.001 2.17 (1.73, 2.72) <0.001 2.18 (1.65, 2.86) <0.001
Good 4.8 (307) 1.00 1.00 1.00
p<0.001
NART errors (8109) 474 472 330
Poor 6.5 (55) 1.10 (0.83, 1.46) 0.4 1.10 (0.83, 1.46) 0.5 1.07 (0.73, 1.56) 0.7
Good 5.8 (419) 1.00 1.00 1.00
p = 0.5
Prospec. memory (8400) 507 505 341
Failure (1574) 13.7 (216) 2.37 (1.98, 2.84) <0.001 2.37 (1.97, 2.84) <0.001 2.36 (1.89, 2.95) <0.001
Success (6826) 4.3 (291) 1.00 1.00 1.00
p<0.001
Composite score (6151) 334 333 230
Poor 19.4 (124) 3.50 (2.75, 4.35) <0.001 3.71 (2.93, 4.70) <0.001 3.51 (2.61, 4.71) <0.001
Good 3.8 (210) 1.00 1.00 1.00
p<0.001
Model 1: Socio-demographic (Age, per 5 years, sex, education, and social class) factors. Model 2: Socio-demographic and lifestyle (smoking, physical activity, and alcohol) factors. Model 3:
Socioeconomic, lifestyle, and biological (cholesterol, systolic blood pressure, BMI, WHR, FEV, and plasma vitamin C) factors and prevalent disease. HVLT, Hopkins Verbal Learning Test, ms,
milliseconds; N, number; PAL-FTMS, Paired Associated Learning, First Trial Memory Score; Pros. Mem, Prospective memory; PW-Acc, PW-Accuracy; SD, standard deviation; SF-EMSE, Short
Form Extended Mental State Exam; Sh-NART, Short National Adult Reading Test; VST, Visual Sensitivity Test.
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Table 4
Association between number of tests with a poor performance score and dementia, adjusting
for all the co-variates (Model 3) and excluding those with dementia prior to attending
the 3HC (N = 4,485)
Model 3
Number of tests where participants Frequency HR 95% CI p
obtained a poor performance score dementia (N)
230
0 (N = 2365) 1.00
1 (N = 1184) 2.18 (1.45,3.27) <0.001
2-3 (N = 745) 4.30 (2.90, 6.39) <0.001
4–8 (N = 200) 10.82 (6.85, 17.1) <0.001
Model 3: Socioeconomic, lifestyle, and biological factors and prevalent disease.
Associations based on the proportion with poor
level of function across the cognitive abilities showed
a steep linear increase in risk of dementia, in indi-
viduals with increasing numbers of abilities with a
poor performance score (Table 4). Compared to those
who did not have a poor performance score in any
test, those with poor performance in one test had
double the risk of dementia, poor performance in
2-3 tests had a four-fold increase, and those with
poor performance in 4–8 tests, had over a ten-fold
increased risk of dementia, HR = 10.82 (95%CI 6.85,
17.1 p = 0.001).
Those with poor cognition in 4–8 tests showed
more variability across domains than those with poor
cognition in fewer domains. Controlling for each of
the cognitive test as well as the composite score
made little difference to the associations, as shown
diagrammatically in Fig. 3 (with the data presented
in Supplementary Table 6); however, adjusting for
HVLT (episodic memory) did attenuate the associa-
tion more than the other cognitive measures. Those
who with poor performance in 4–8 tests were more
likely to be older, have no qualifications, have higher
reporting rate of heart attack, hypertension, stroke,
diabetes, and memory and hearing problems. The
mean score for all the cognition tests were substan-
tially lower for this group, including a much higher
NART error score. (Supplementary Table 7).
The supplementary analysis of the ROC curves as
shown in Supplementary Figure 1 show the accu-
racy of the models presented in this study. The AUC
successively improved from the basic model with
addition of the covariates (Model 3), further with
cognitive measure (shown here with the composite
score); with the greatest predictive power of the final
model which included ‘number of tests’. AUC val-
ues for these models for the individual tests (with the
odds ratios from the multiple logistic regression used
to generate the predicted probabilities) are presented
in Supplementary Tables 8 and 9. These findings need
to be examined in further studies
DISCUSSION
We report on eight simple cognitive measures for
which poor performance is associated with increased
future risk of dementia in individuals with almost
fifteen years of follow up. Impairment occurs in
multiple domains several years prior to any clini-
cal symptoms, and the more pervasive and greater
the variability, the higher the risk of dementia. Our
study presents additional evidence on the utility of a
range of cognitive tests and the risk of dementia in
this cohort of men and women in mid to later life who
were free of dementia at the time of cognitive testing.
Impairment in multiple domains independently
were associated with an increased risk of dementia
over and above performance score of individual tests
or a composite score. Poor cognition in four or more
tests is associated with a ten-fold increased risk of
developing dementia compared to those not perform-
ing poorly in any test. To our knowledge, no other
study has examined associations with future incident
dementia in detail, across a broad range of cognitive
tests. Previous studies have either used a global com-
posite or standardized score and not examined the
relationship to include extent of impairment, nor a
longer follow-up time as we have done here.
We have added to the current knowledge that extent
of dysfunction, even at an earlier and milder level,
has a substantial increased risk of future demen-
tia. Adding cognition score to the multivariable
adjusted model alone, showed an improvement in
the accuracy of the model (AUC = 0.83 and 0.81,
respectively), a finding that is comparable to other
studies of risk prediction models [19, 21]. How-
ever, by incorporating the number of tests with
impaired cognition, the model improved even further
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Fig. 3. Diagrammatic representation of association of level of cognitive impairment and dementia controlling for each of the cognitive test.
(AUC = 0.85). These findings provide further insight
to cognitive predictors commonly included as compo-
nents in risk prediction and could potentially inform
future dementia prediction models. This is a novel
and important finding and warrants further investiga-
tion. Although examining risk prediction is beyond
the scope of this current study, the impact of adding
level of impairment to accuracy of the model for a
future risk prediction study should be examined in
other studies.
There are a number of limitations to this study.
The first is of healthy volunteer bias of those individ-
uals attending the 3HC phase. However, our study
included a wide range of individuals in terms of age,
education, social class, and both men and women
as in the general population [42]. Although EPIC-
Norfolk was originally initiated as a general health
study, the focus of the 3HC was on aspects of ageing,
and so participants attending could have had concerns
about their cognition. Those who did not attend this
interview but had given permission to track medi-
cal records had 83% higher risk of dementia than
those who attended and did all eight cognitive test
HR = 1.83 (95%CI 1.61, 2.08 p≤0.001). While the
absolute rates of dementia in the participants who
undertook the cognitive function testing may not
reflect those of a more general population, neverthe-
less there was still a wide range of ability in terms of
cognitive performance.
The use of a self-report measure of many of the fac-
tors may also be criticized as prone to recall biases or
not accurate as an objective measure. Conducting this
study in this healthier population has the advantage of
less confounding from co-morbidities. Although we
adjusted for a wide range of factors, due to the nature
of an observational study, we cannot exclude resid-
ual confounding. Given that this study is in relatively
healthy older adults, we used a relatively stringent
cut-off (even though the more stringent cut-off will
still include cognitively poor but healthy individuals).
Using medical records allows a more complete
follow-up, limiting attrition as a bias and is widely
used method in epidemiological research [21]. The
downside of this is the dependence on medical
records, prone to inconsistencies across time, with
changes in policy and practice raising concerns over
the accuracy and changing completeness of demen-
tia recording [44, 45]. Also, medical records are
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known to underestimate the number of individuals
with dementia, as not all individuals receive a formal
diagnosis. Nevertheless, even though less sensitive,
medical record diagnosis is likely to be highly spe-
cific such that when an individual has a diagnosis
or death certification with dementia recorded this is
highly likely to be accurate [45].
Although we found minimal change in associations
when omitting in sensitivity analyses those who had
died or had a dementia diagnosis within 5 years of
cognitive testing, we cannot rule out reverse causa-
tion as dementia has such a long preclinical phase
[46]. Further follow-up time is needed. However,
determining temporality for dementia will always be
challenging. Also, having a wide age range at base-
line, we were able to observe the different influence of
factors and how their relationship varied with demen-
tia as midlife or later life exposures.
Substantial cognitive changes occur with healthy
ageing. Previous studies have shown that there are
milder or pre-symptomatic stages of dementia, not
limited to memory [30, 31]. We have confirmed these
findings in this larger cohort with a wider age range. It
is quite possible to misclassify milder symptoms or
asymptomatic without memory concerns as normal
cognitive ageing. Our findings show the magnitude
of the association between a wide range of cogni-
tive tests from the same cohort, with some tests more
strongly associated than others. In particular, we show
tests of processing speed are not as strongly related as
the other tests. These points are important to consider
in future work.
Variation in methodology, characteristics of the
population, the timing and nature of cognitive test
will all influence the association. It is essential to
disentangle confounding to get a better understand-
ing of the causal pathways and those at greatest risk.
In our study, the future relative risk was ten-fold
greater in those with pervasive impairment. Other
cohort studies examining dementia risk should con-
sider impairment across multiple domains to examine
the association within their settings.
It is important to highlight, that even with a ten-
fold increased risk of dementia in those with more
pervasive impairments, there is insufficient evidence
to advocate screening or use of predictive mod-
elling for diagnostic use for dementia. There is still
much to understand in terms of to provide further
insight into the different domains cognitive function
commonly used for assessment as components in
dementia risk modelling. These findings may be used
to develop future prediction models to identify earli-
est phases of impairment across cognitive domains,
to inform the design of trials of preventive or modify-
ing interventions [5] and identify target populations
greatest at risk who can then also be included in such
trials.
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